Company / EPS (Basic)
Edwards Lifesciences EPS (Basic) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
$1.84
FY2025
5-year range
$1.84 / $2.46
FY2021-FY2025
Trend
-25.2%
vs FY2024
Sector context
#59 of 160
Health Care
What the data says
At $1.84, Edwards Lifesciences's eps (basic) ranks #59 of 160 in the Health Care sector. EPS (Basic) has fluctuated over the past 10 years, ranging from $1.15 in FY2018 to $2.67 in FY2016.
Based on SEC 10-K filings.
1.84 in FY2025 with a 5-year CAGR of +6.9%.
Declined from $2.41 to $1.84 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -9.2%
- 5-Year CAGR
- +6.9%
- 10-Year CAGR
- -
Sector benchmark
#59 of 160 in Health CareTop 37% of 160This company $1.84 Sector average $1.57
▼
+16.9% above sector average
Key checks
Key Insights
- In FY2025, eps (basic) decreased 25.2% year-over-year.
- Ranks #59 out of 160 companies in the Health Care sector.
- Peak eps (basic) was recorded in FY2016.
- Lowest eps (basic) in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 3.16 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.84 | -25.2% |
| FY2024 | $2.46 | +2.1% |
| FY2023 | $2.41 | -2.0% |
| FY2022 | $2.46 | +2.1% |
| FY2021 | $2.41 | +82.6% |
| FY2020 | $1.32 | -21.4% |
| FY2019 | $1.68 | +46.1% |
| FY2018 | $1.15 | -50.0% |
| FY2017 | $2.30 | -13.9% |
| FY2016 | $2.67 | +53.4% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026